Name:
YONDELIS (development of innovative drugs through marine organisms)

Developed by:
PHARMAMAR, SPAINSpain

Funding sources:
National

General idea:
APLIDIN is an anticancer agent of marine origin, originally obtained from the ascidian Aplidium albicans.

TRL:
9. Actual system proven in operational environment

IPR involved:
Yes

Sources:
Literarute review. Link: https://pharmamar.com/science-and-innovation/oncology-pipeline/?lang=en